Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials

E Kedhi; R Delewi; E Fabris; G de Luca; RS Hermanides; M Ent; P Buszman; Felix Zijlstra; YB Song; HC Gwon; JY Hahn

doi:10.1016/j.atherosclerosis.2020.11.003

Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials

E Kedhi, R Delewi, E Fabris, G de Luca, RS Hermanides, M Ent, P Buszman, Felix Zijlstra, YB Song, HC Gwon, JY Hahn

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	55-61
Number of pages	7
Journal	Atherosclerosis
Volume	315
DOIs	https://doi.org/10.1016/j.atherosclerosis.2020.11.003
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/j.atherosclerosis.2020.11.003

http://hdl.handle.net/1765/131674

Cite this

@article{830fcfb0f93e4898b6ee3f8ba7473095,

title = "Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials",

author = "E Kedhi and R Delewi and E Fabris and {de Luca}, G and RS Hermanides and M Ent and P Buszman and Felix Zijlstra and YB Song and HC Gwon and JY Hahn",

year = "2020",

doi = "10.1016/j.atherosclerosis.2020.11.003",

language = "English",

volume = "315",

pages = "55--61",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials

AU - Kedhi, E

AU - Delewi, R

AU - Fabris, E

AU - de Luca, G

AU - Hermanides, RS

AU - Ent, M

AU - Buszman, P

AU - Zijlstra, Felix

AU - Song, YB

AU - Gwon, HC

AU - Hahn, JY

PY - 2020

Y1 - 2020

U2 - 10.1016/j.atherosclerosis.2020.11.003

DO - 10.1016/j.atherosclerosis.2020.11.003

M3 - Article

C2 - 33227548

SN - 0021-9150

VL - 315

SP - 55

EP - 61

JO - Atherosclerosis

JF - Atherosclerosis

ER -